Activated protein C: cost-effective or costly?

The authors offer a commentary on the study by Dhainaut et al. on the cost-effectiveness of activated protein C in severe sepsis. Using data from "real world" conditions, the results of this economic evaluation are consistent with previous analyses, and highlight the need for "real wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brar, Savtaj Singh, Manns, Braden J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556732/
https://www.ncbi.nlm.nih.gov/pubmed/17875223
http://dx.doi.org/10.1186/cc6090
_version_ 1782159590917406720
author Brar, Savtaj Singh
Manns, Braden J
author_facet Brar, Savtaj Singh
Manns, Braden J
author_sort Brar, Savtaj Singh
collection PubMed
description The authors offer a commentary on the study by Dhainaut et al. on the cost-effectiveness of activated protein C in severe sepsis. Using data from "real world" conditions, the results of this economic evaluation are consistent with previous analyses, and highlight the need for "real world" investigations of new health technologies in critical care.
format Text
id pubmed-2556732
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25567322008-10-01 Activated protein C: cost-effective or costly? Brar, Savtaj Singh Manns, Braden J Crit Care Commentary The authors offer a commentary on the study by Dhainaut et al. on the cost-effectiveness of activated protein C in severe sepsis. Using data from "real world" conditions, the results of this economic evaluation are consistent with previous analyses, and highlight the need for "real world" investigations of new health technologies in critical care. BioMed Central 2007 2007-09-10 /pmc/articles/PMC2556732/ /pubmed/17875223 http://dx.doi.org/10.1186/cc6090 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Commentary
Brar, Savtaj Singh
Manns, Braden J
Activated protein C: cost-effective or costly?
title Activated protein C: cost-effective or costly?
title_full Activated protein C: cost-effective or costly?
title_fullStr Activated protein C: cost-effective or costly?
title_full_unstemmed Activated protein C: cost-effective or costly?
title_short Activated protein C: cost-effective or costly?
title_sort activated protein c: cost-effective or costly?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556732/
https://www.ncbi.nlm.nih.gov/pubmed/17875223
http://dx.doi.org/10.1186/cc6090
work_keys_str_mv AT brarsavtajsingh activatedproteinccosteffectiveorcostly
AT mannsbradenj activatedproteinccosteffectiveorcostly

Ejemplares similares